MGC Diagnostics (MGCD) Misses Q2 EPS by 6c

MGC Diagnostics (NASDAQ: MGCD) reported Q2 EPS of $0.07, $0.06 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $7.4 million, versus $7.6 million reported last year.

For earnings history and earnings-related data on MGC Diagnostics (MGCD) click here.

You May Also Be Interested In

• Coherent posts a blowout Q4 and aggressive guidance, yet shares take a 5% haircut
• Usio, Inc. (USIO) Tops Q2 EPS by 2c
• EnerSys (ENS) Tops Q1 EPS by 84c; offers guidance